Kallisio is redefining what's possible with patient-specific therapeutic systems that integrate seamlessly into clinical workflows and deliver precision care at scale.
A precision therapy solution built to optimize head and neck radiation, the Stentra System integrates:
3D visualization outputs to support clinician planning
Cloud-based traceability from design to verification
Patient-specific 3D printed intraoral device to optimize dose delivery
Validated across real-world settings, the Stentra System drives reproducibility, enhances workflow efficiency, and supports improved patient outcomes.
Connect with Us to Explore Collaborating
At the upcoming ASTRO conference we'll be showcasing the full capabilities of our Stentra System alongside partner Ricoh 3D for Healthcare. Schedule time with our team beforehand to explore:
The complete digital workflow behind Stentra
Collaboration opportunities across manufacturing and distribution
Real-world feedback from early-adopting cancer centers
Find us at Booth #1042 duringThe 2025 ASTRO Annual Meeting held at the Moscone Center in San Francisco, California, from September 27th to October 1st.
Creating Opportunity for Cancer Centers
Through our Proof-of-Value program, we've enabled top-tier cancer centers to trial the Stentra System directly within their clinical workflow. Early results are demonstrating:
Simulation efficiencies and time savings
Better reproducibility in treatment planning
Enhanced protection of organs at risk and high patient tolerance
These partnerships are converting to long-term adoption and signal growing demand for scalable, patient-specific interventions.
Join Us in Scaling Precision Therapy
We're actively building new partnerships with manufacturers, distributors and investors to bring this innovation to more patients worldwide. If your organization is aligned with the future of personalized cancer care, we'd love to connect.
Comments
Post a Comment